-

    updated on 20 August, 2026

Bridging the gap: 3D and advanced models for nanomedicine and tissue regeneration

 
   16 Sept. clessidra che gira 14:00 - 15:30
ROOM 17
energy
HEALTH & NANOMEDICINE
01 ADDITIVE & 3D MANUFACTURING
ADDITIVE & 3D MANUFACTURING
TT.III - Technical Parallel Track Sessions
Bridging the gap: 3D and advanced models for nanomedicine and tissue regeneration
Co-organised with University of Magna Graecia
Chairs: Laura CATENACCI & Michela SORRENTI, University of Pavia

This session will explore the integration of advanced experimental models and nanotechnology to bridge the gap between fundamental research and biomedical applications. Particular attention will be given to innovative in vitro and preclinical models, advanced delivery platforms, and emerging approaches for studying biological interactions, tissue regeneration, and therapeutic responses. The session will highlight how physiologically relevant models can support the development, evaluation, and translation of novel nanomedicine-based strategies.

The symposium is part of FE.I
TT.III.G.1
FE.I.6.1
Sara PERTEGHELLA, University of Pavia, Department of Drug Sciences
In vitro models for nose-to-brain delivery studies applied to nanoformulations
Virginie SOTTILE - CV, University of Pavia, Department of Molecular Medicine
Preclinical models of stem cell differentiation and tissue formation
PERTEGHELLA Sara SOTTILE Virginie  
TT.III.G.2
FE.I.6.2
Edoardo BERTANIA - CV
University of Piemonte Orientale
One platform, multiple carriers: microfluidics for nanoparticle- and vesicle-based drug delivery
BERTANIA Edoardo  
TT.III.G.3
FE.I.6.3
Sofia BELLIA - CV
University of Palermo
Nanomedicine for brain drug delivery: from design to microfluidic and 3D neurospheroid models
BIELLA Sofia  
TT.III.G.4
FE.I.6.4
Rachele ROSSI - CV
University of Pavia
Nucleic acid-loaded lipid nanoparticles optimization and interaction with biological substrates
ROSSI Rachele  
TT.III.G.5
FE.I.6.5
Federica TIBERIO - CV
Università Cattolica del Sacro Cuore
Nano-ink–mediated RNA therapy for non-invasive treatment of craniofacial disorders
TIBERIO Federica 2  
 

 

 
freccia SX f54 Back to Fields & Topics Back to Plan 16 September freccia DX f54
 

 

INFO & CONTACTS

This email address is being protected from spambots. You need JavaScript enabled to view it.